Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia

Registered report: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukemia

The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of selected experiments from a number of high-profile papers in the field of cancer biology. The papers, which were published between 2010 and 2012, w...

Full description

Bibliographic Details
Main Authors:	Juan José Fung, Alan Kosaka, Xiaochuan Shan, Gwenn Danet-Desnoyers, Michael Gormally, Kate Owen, Reproducibility Project: Cancer Biology
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2015-09-01
Series:	eLife
Subjects:	Reproducibility Project: Cancer Biology methodology bromodomain inhibitor leukemia
Online Access:	https://elifesciences.org/articles/08997

Similar Items

Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
by: Xiaochuan Shan, et al.
Published: (2017-06-01)

Correction: Replication Study: Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
by: Xiaochuan Shan, et al.
Published: (2018-01-01)

Registered report: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
by: Irawati Kandela, et al.
Published: (2015-06-01)

Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
by: Fraser Aird, et al.
Published: (2017-01-01)

Registered report: Intestinal inflammation targets cancer-inducing activity of the microbiota
by: Kate Eaton, et al.
Published: (2015-03-01)

Registered report: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
by: John Repass, et al.
Published: (2016-02-01)

Registered report: A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations
by: Babette Haven, et al.
Published: (2016-02-01)

Registered report: COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
by: Vidhu Sharma, et al.
Published: (2016-03-01)

The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins
by: Yasushi Taniguchi
Published: (2016-11-01)

Registered report: Discovery and preclinical validation of drug indications using compendia of public gene expression data
by: Irawati Kandela, et al.
Published: (2015-05-01)

Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
by: Israr Khan, et al.
Published: (2015-09-01)

Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases
by: Brad Evans, et al.
Published: (2015-07-01)

The Functions of BET Proteins in Gene Transcription of Biology and Diseases
by: Ka Lung Cheung, et al.
Published: (2021-09-01)

Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers
by: Vidhu Sharma, et al.
Published: (2016-02-01)

The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats
by: Jérôme Piquereau, et al.
Published: (2019-03-01)

Registered report: Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
by: David Blum, et al.
Published: (2014-12-01)

Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
by: John Repass, et al.
Published: (2018-03-01)

Registered report: Widespread potential for growth factor-driven resistance to anticancer kinase inhibitors
by: Edward Greenfield, et al.
Published: (2014-12-01)

Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
by: Irawati Kandela, et al.
Published: (2015-05-01)

Registered report: Melanoma genome sequencing reveals frequent PREX2 mutations
by: Denise Chroscinski, et al.
Published: (2014-12-01)

Registered report: Transcriptional amplification in tumor cells with elevated c-Myc
by: David Blum, et al.
Published: (2015-01-01)

Replication Study: The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
by: Stephen K Horrigan, et al.
Published: (2017-01-01)

Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
by: Jia Li, et al.
Published: (2015-07-01)

Registered report: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
by: Denise Chroscinski, et al.
Published: (2015-02-01)

Registered report: Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF
by: Ajay Bhargava, et al.
Published: (2016-02-01)

Registered report: The CD47-signal regulated protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
by: Denise Chroscinski, et al.
Published: (2015-01-01)

Replication Study: Discovery and preclinical validation of drug indications using compendia of public gene expression data
by: Irawati Kandela, et al.
Published: (2017-01-01)

Small molecules remain on target for c-Myc
by: Linchong Sun, et al.
Published: (2017-01-01)

Registered report: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
by: Mitch Phelps, et al.
Published: (2016-03-01)

Registered report: Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
by: Samrrah Raouf, et al.
Published: (2015-01-01)

Registered report: Systematic identification of genomic markers of drug sensitivity in cancer cells
by: John P Vanden Heuvel, et al.
Published: (2016-06-01)

Pharmacological Modulation of BET Family in Sepsis
by: Nian Wang, et al.
Published: (2021-03-01)

Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota
by: Kathryn Eaton, et al.
Published: (2018-10-01)

Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs
by: Christine Mantis, et al.
Published: (2017-01-01)

Registered report: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
by: Ajay Bhargava, et al.
Published: (2016-02-01)

Development of a Novel Positron Emission Tomography (PET) Radiotracer Targeting Bromodomain and Extra-Terminal Domain (BET) Family Proteins
by: Ping Bai, et al.
Published: (2020-08-01)

Role of BET Inhibitors in Triple Negative Breast Cancers
by: Durga Khandekar, et al.
Published: (2020-03-01)

Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
by: John Kerwin, et al.
Published: (2020-04-01)

Maintenance of muscle myosin levels in adult C. elegans requires both the double bromodomain protein BET-1 and sumoylation
by: Kate Fisher, et al.
Published: (2013-10-01)

Inhibition of BET Proteins during Adolescence Affects Prefrontal Cortical Development: Relevance to Schizophrenia
by: Wiktor Bilecki, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_g32p6u9edfn8g0ae30tdpe9imj